139 related articles for article (PubMed ID: 27797443)
1. Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa.
Shearer K; Evans D; Moyo F; Rohr JK; Berhanu R; Van Den Berg L; Long L; Sanne I; Fox MP
Trop Med Int Health; 2017 Feb; 22(2):221-231. PubMed ID: 27797443
[TBL] [Abstract][Full Text] [Related]
2. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
Evans D; Hirasen K; Berhanu R; Malete G; Ive P; Spencer D; Badal-Faesen S; Sanne IM; Fox MP
AIDS Res Ther; 2018 Apr; 15(1):10. PubMed ID: 29636106
[TBL] [Abstract][Full Text] [Related]
3. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.
Rohr JK; Ive P; Horsburgh CR; Berhanu R; Shearer K; Maskew M; Long L; Sanne I; Bassett J; Ebrahim O; Fox MP
PLoS One; 2016; 11(8):e0161469. PubMed ID: 27548695
[TBL] [Abstract][Full Text] [Related]
4. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
[TBL] [Abstract][Full Text] [Related]
5. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes among HIV-positive orphaned and non-orphaned children on antiretroviral therapy in Johannesburg, South Africa.
Hendrickson C; Evans D; Brennan AT; Patz S; Untiedt S; Bassett J; Levin L; Sanne I; Fox MP
S Afr Med J; 2019 Aug; 109(9):679-685. PubMed ID: 31635594
[TBL] [Abstract][Full Text] [Related]
7. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa.
Shearer K; Fox MP; Maskew M; Berhanu R; Long L; Sanne I
PLoS One; 2013; 8(8):e71719. PubMed ID: 23940782
[TBL] [Abstract][Full Text] [Related]
8. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
[TBL] [Abstract][Full Text] [Related]
9. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.
Fox MP; Cutsem GV; Giddy J; Maskew M; Keiser O; Prozesky H; Wood R; Hernán MA; Sterne JA; Egger M; Boulle A;
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):428-37. PubMed ID: 22433846
[TBL] [Abstract][Full Text] [Related]
10. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa.
Shearer K; Brennan AT; Maskew M; Long L; Berhanu R; Sanne I; Fox MP
J Int AIDS Soc; 2014; 17(1):19065. PubMed ID: 25361827
[TBL] [Abstract][Full Text] [Related]
11. Effective public-private partnerships for sustainable antiretroviral therapy: outcomes of the Right to Care health services GP down-referral program.
Mokhele I; Mashamaite S; Majuba P; Xulu T; Long L; Onoya D
BMC Public Health; 2019 Nov; 19(1):1471. PubMed ID: 31699063
[TBL] [Abstract][Full Text] [Related]
12. Second-line antiretroviral therapy: long-term outcomes in South Africa.
Murphy RA; Sunpath H; Castilla C; Ebrahim S; Court R; Nguyen H; Kuritzkes D; Marconi VC; Nachega JB
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):158-163. PubMed ID: 22692090
[TBL] [Abstract][Full Text] [Related]
13. Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa.
Shearer K; Clouse K; Meyer-Rath G; MacLeod W; Maskew M; Sanne I; Long L; Fox MP
BMJ Open; 2017 Jan; 7(1):e013908. PubMed ID: 28119389
[TBL] [Abstract][Full Text] [Related]
14. Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.
Onyedum CC; Iroezindu MO; Chukwuka CJ; Anyaene CE; Obi FI; Young EE
Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):608-14. PubMed ID: 23959002
[TBL] [Abstract][Full Text] [Related]
15. Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.
Court R; Leisegang R; Stewart A; Sunpath H; Murphy R; Winternheimer P; Ally M; Maartens G
BMC Infect Dis; 2014 Dec; 14():664. PubMed ID: 25472544
[TBL] [Abstract][Full Text] [Related]
16. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
Fatti G; Mothibi E; Shaikh N; Grimwood A
AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
[TBL] [Abstract][Full Text] [Related]
17. Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa.
Bell Gorrod H; Court R; Schomaker M; Maartens G; Murphy RA
J Acquir Immune Defic Syndr; 2020 May; 84(1):107-113. PubMed ID: 32032304
[TBL] [Abstract][Full Text] [Related]
18. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
19. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
[TBL] [Abstract][Full Text] [Related]
20. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
